<DOC>
	<DOCNO>NCT00525096</DOCNO>
	<brief_summary>To discover add coxib increase efficacy Aromasine .</brief_summary>
	<brief_title>Exemestane + Celecoxib v Exemestane + Placebo Metastatic Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Exemestane</mesh_term>
	<criteria>Femal patient age &gt; 18 year Histologically proven breast cancer Menopausal patient accord follow definition : amenorrhoea &gt; 1 year menopause affirm rate oestradiol hypophyseal gonadotrophin surgical ovariectomy treatment LHRH analog ovarian suppression radiotherapy amenorrhoea induce chemotherapy &gt; 1 year Oestradiol and/or progesterone positive receptor Presence one several metastatic lesion : mesurable lesion bone metastase detect bone scintigraphy Patient receive : Adjuvant chemotherapy and/or hormonotherapy ( Tamoxifen ) Metastatic Treatment chemotherapy PS &lt; 2 Adequate biological value Patient clearly give consent signing informed consent form prior participation Patient previously treat hormonotherapy metastatic phase Antecedent treatment aromatase inhibitor local relapse ( exception cutaneous thoracic node ) Patient one metastatic lesion like : pleurisy , ascites , lung Lymphangitis carcinomatosa</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>